Founder & President
David Berglund, M.D., Ph.D., M.B.A., is an Associate Professor of Immunology that has published more than 40 peer-reviewed articles in areas ranging from transplant immunology and oncology to transfusion medicine and biomaterials. David also received clinical training in transplant and reconstructive plastic surgery at Uppsala University Hospital and Karolinska University Hospital in Sweden. He has worked with drug development for more than 10 years focusing on strategic leadership of both early- and late-stage pharmaceutical companies. David holds an M.B.A. from NYU Stern School of Business with specializations in Corporate Finance and Leadership & Change Management.